Alnylam Pharmaceuticals
ALNY
#727
Rank
โ‚ฌ30.58 B
Marketcap
228,54ย โ‚ฌ
Share price
-0.65%
Change (1 day)
-40.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company